HEF-1α, HPSE and VEGF promote malignant progression of retinoblastoma

Chinese Journal of Ophthalmology

Volumn 46, Issue 2, 2010, Pages 140-144

  Wang, Xiao Lei ^a   Niu, Ying Jun ^a   Ma, Jian Min ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Alpha subunit; Glucuronidase; Hypoxia inducible factor1; Immunohistochemistry; Retinoblastoma; Reverse transcriptase polymerase chain reaction; Vascular endothelial growth factor a

Indexed keywords

BETA GLUCURONIDASE; HEPARANASE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CANCER STAGING; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RETINA TUMOR; RETINOBLASTOMA; VASCULARIZATION;

GLUCURONIDASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RETINAL NEOPLASMS; RETINOBLASTOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956528504     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.04124081.2010.02.010     Document Type: Article

References (12)

1. Brun R, Naroditsky I, Waterman M, et al. Heparanase expression by Barrett' s epithelium and during esophageal carcinoma progression. Mod Pathol, 2009, 9:1-7.
2. Boyd DD, Nakajima M. Involvement of heparanase in tumor metastases: a new target in cancer therapy. J Natl Cancer Inst, 2004, 96: 1194-1195.
3. Li J, Saif MW. Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers.. Biologics, 2009, 3 : 429-441.
4. Yasuda S, Arii S, Mori A, et al. Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. J Hepatol, 2004, 40:117-123.
5. Birner P, Schindl M, Obermair A, et al. Overexpression of hypoxia inducible factor-la is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res, 2000, 60; 4693-4696.
6. Kinoshita I, Kitamura K, Kabashima A, et al. Clinical significance of vascular endothelial growth factor-C ( VEGF-C ) in breast cancer. Breast Cancer Res Treat, 2001, 66:159-164.
7. Marrogi AJ, Travis WD, Welsh JA, et al. Nitric oxide synthase, cyclooxygenase 2 and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res, 2000, 6:47394744.
8. Zhong H, Semenza GL, Simons JW, et al. Up-regulation of hypoxia inducible factorl alpha is an early event in carcinogenesis. Cancer Detect Prev, 2004, 28: 88-93.
9. Paschos KA, Canovas D, Bird NC. Enzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases. Hippokratia,2009, 13: 23-31.
10. Stȩpień T, Sacewicz M, Lawnicka H, et al. Stimulatory effect of growth hormone-releasing hormone (GHRH(I -29 ) NH2 ) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro. Neuropeptides, 2009, 43:397400.
11. Inoue K, Kamada M, Slaton JW, et al. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Clin Cancer Res, 2002, 8:1863-1870.
12. Ren XQ, Meng JM, Fu KD. Study on relationship between expression of p53, HIF-1α and angiogengesis of colorectal carcinoma. China Medical Engineering, 2004, 12:31-35.